Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 16/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27265861 | 0.82 | RAPGEF4 (0.57) | RAPGEF4ALDH1A1FFAR4 | |
| SCHEMBL23009590 | 0.82 | RAPGEF4 (0.50) | RAPGEF4ALDH1A1 | |
| SCHEMBL19629086 | 0.78 | RAPGEF4 (0.46) | RAPGEF4ALDH1A1FFAR4 | |
| SCHEMBL502929 | 0.78 | RAPGEF4 (1.00) | RAPGEF4 | |
| SCHEMBL14878894 | 0.77 | ALDH1A1 (0.43) | RAPGEF4ALDH1A1 | |
| SCHEMBL29021130 | 0.77 | HTR1D (0.41) | RAPGEF4ALDH1A1 | |
| SCHEMBL24849731 | 0.77 | CYP3A4 (0.55) | RAPGEF4ALDH1A1 | |
| SCHEMBL5094596 | 0.75 | METAP2 (0.57) | RAPGEF4ALDH1A1 | |
| SCHEMBL8204442 | 0.75 | ALDH1A1 (0.50) | RAPGEF4ALDH1A1FFAR4 | |
| SCHEMBL18495129 | 0.75 | RAPGEF4 (0.41) | RAPGEF4ALDH1A1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117925054-A | Water-based epoxy antirust paint and preparation method thereof | 江门市制漆厂有限公司 | 2024-04-26 | — | — | CN | claimed |
| US-20200369689-A1 | Arylaminosilane Compound, Propylene Polymerization Catalyst And Preparation Thereof | PETROCHINA COMPANY LIMITED (CN) | 2020-11-26 | — | — | US | claimed |
| CN-111978346-A | Arylamine silane compound, propylene polymerization catalyst, preparation and application thereof | 中国石油天然气股份有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-107698697-A | A kind of triazole of claw type 1,4 connects cyclodextrin molecular and preparation method and application more | 昆明理工大学 | 2018-02-16 | — | — | CN | claimed |
| US-20090107555-A1 | Dual Function Fuel Atomizing and Ignition Additives | AFTON CHEMICAL CORPORATION | 2009-04-30 | — | — | US | claimed |
| EP-1066269-B1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2005-05-11 | — | — | EP | claimed |
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | DAEYAERT FREDERIK FRANS DESIRE (BE) | 2002-08-22 | — | — | US | claimed |
| EP-1066269-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-01-10 | — | — | EP | claimed |
| US-6150360-A | ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-11-21 | — | — | US | claimed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | claimed |
| CN-117925054-A | Water-based epoxy antirust paint and preparation method thereof | 江门市制漆厂有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20240018279-A1 | Cyclic Containing Polymer Compositions Obtained Using Transition Metal Bis(Phenolate) Catalyst Complexes and Process for Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-01-18 | — | — | US | disclosed |
| EP-3911647-B1 | ISOXAZOLE COMPOUND AS FXR AGONIST AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | GILEAD SCIENCES INC (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-3341358-B1 | PREPARATION OF SULFONAMIDE-CONTAINING ANTIMICROBIALS AND SUBSTRATE TREATING COMPOSITIONS OF SULFONAMIDE-CONTAINING ANTIMICROBIALS | NANO SAFE COATINGS INCORPORATED A FLORIDA CORP 3 P 14000024914 (US) | 2023-03-08 | — | — | EP | disclosed |
| US-11535638-B2 | Arylaminosilane compound, propylene polymerization catalyst and preparation thereof | PETROCHINA COMPANY LIMITED (CN) | 2022-12-27 | — | — | US | disclosed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | disclosed |
| CN-1008101-B | PROCESS OF PRODUCTION FOR POLYPHENYL ETHER | ASAHI CHEMICAL IND (JP) | 1990-05-23 | — | — | CN | disclosed |
| US-4788277-A | OXIDATIVE COUPLING, CATALYST CONTAINING COPPER, DIAMINE, HALOGEN | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-11-29 | — | — | US | disclosed |
| CN-87107289-A | The production method of polyphenylene oxide | — | 1988-06-15 | — | — | CN | disclosed |
| US-4254214-A | BLACK, REDUCTION OF COPPER SALT OR COMPLEX TO COPPER | FUJI PHOTO FILM CO., LTD. (JP) | 1981-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | XDH, CCR5, CXCR1 | RAPGEF4 4453/4885ALDH1A1 3722/4885FFAR4 997/4885 |
| US-11535638-B2 | Arylaminosilane compound, propylene polymerization catalyst and preparation thereof | RPS8, PARP8, PRMT8 | RAPGEF4 668/4885ALDH1A1 2737/4885FFAR4 1936/4885 |
| US-20200369689-A1 | Arylaminosilane Compound, Propylene Polymerization Catalyst And Preparation Thereof | RPS8, PARP8, PRMT8 | RAPGEF4 668/4885ALDH1A1 2737/4885FFAR4 1936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.